Revo Island

1.

No, exposing people to products that are not proven to be safe is unethical. Although these companies use advanced genes and procedures to produce products, they may also cause side effects for people. It can cause outbreaks of infectious diseases and diseases in the environment that can affect entire countries. Officials should always take a wait-and-see approach to the ecological impact of such treatment.

2.

It is unethical for community leaders to expose their citizens to the risk of a deadly disease such as dengue fever when there is already a proven way to reduce the impact of the disease. We know from the fact that dengue affects the body by causing high fever and flu-like symptoms. The virus infects the blood and causes migraines such as headaches, rashes, pain, nausea and fever. It can affect the blood, cause the gums to bleed slightly and bruise easily.

At the same time, I also think it is absolutely critical that community leaders take care of their citizens and protect them from this dangerous disease, especially when there is a proven way to reduce the impact of this disease.

3.

Companies should be able to test the safety of these products by using test subjects who have given PERMISSION to be test subjects, to help a greater cause.

4.

Layer 1, Oxitec

Affected by Oxitec actions.

They are responsible for the production of the "disease-killing" mosquitoes.

Oxitec is fully responsible for this product, and Oxitec should be held responsible regardless of whether the results are positive or negative.

Layer 2, Cities that need the production of mosquitoes / Financials / Consumers

Affected by Oxitec actions.

Cities are the main source of funding for these mosquitoes, and after good results are produced, they may need more mosquitoes, which could affect the city's environment.

Oxitec may or may not provide the right supply and demand.

Layer 3, Suppliers

Affected by Oxitec actions.

Because of the terrible outbreak of dengue, Oxitec may look to other suppliers for cheaper production.

Large numbers of genetic mosquitoes will have a major economic and profit impact. If Oxitec switches suppliers, the manufacturer could suspend operations to produce more mosquitoes or genetic mosquito tools.

5.

Oxitec is a biotechnology company based in the United Kingdom. The company works on controlling insects that harm crops and spread disease. These insects are controlled through the development of genetically modified insects. Using the business model canvas, Oxitec's business model is described as follows:

1. Key partners - various health departments and agencies in Brazil, the United States, the Cayman Islands, Panama and India are working with Oxitec to prevent the spread of the disease through insect control. Agricultural growers and governments are also working with Oxitec to minimize the loss of food production.

2. Key activity - Oxitec's key activity is to use advanced genetics to reduce the local mosquito population through the use of self-limiting genes.

3. Value proposition - The core value offered by Oxitec is the protection of agricultural growers by reducing crop damage from pests. Another core value is to minimize the spread of disease.

4. Customer relationships - Oxitec integrates its relationship with its customers into its business form and business cost. Build synergies with customers.

And I suggest that, when in the future companies should get regulatory approval from different countries around the world regarding their self-limiting strains. This will help them expand their reach and thus their business.